View all dosages and compare prices:
💊 Buy Mounjaro — all dosages →
Buy Mounjaro 12.5 mg
Final weight loss stage — maximum results
in Ukraine · Original Eli Lilly (UK) · Thermobox delivery
4 injections per pen · UK version by Eli Lilly
Ships today · before 19:00
Delivery Sat, Jun 27 · Nova Poshta
Enhanced Mounjaro pen 12.5 mg for the final stage of your program. Maximum effectiveness for reaching your target weight.
Enhanced dose for reaching your target weight. Only upon specialist recommendation.
Specialist support included in the price
A personal DOZA specialist supports you throughout the entire course — from the first consultation to results. No extra fees: support is already included in the product price.
DOZA offers the original UK version of Mounjaro 12.5 mg
Eli Lilly and Company Limited (United Kingdom), registered by MHRA for the UK market. Not Indian generics, not the US version (FDA), not Chinese copies. You can verify authenticity by the serial number on the packaging.
Why specifically the UK version? After incidents with DE and ES supply chains — where storage conditions were compromised and clients didn't achieve expected results — we chose exclusively the British Eli Lilly supply chain. It has the strictest post-Brexit transport controls for GLP-1 products.
Free specialist consultation
Benefits of Mounjaro 12.5 mg
- ✓Enhanced effectiveness for significant weight loss: -18 to -22 kg
- ✓Near-maximum GLP-1 + GIP action
- ✓Suitable for final program stage
- ✓Original Eli Lilly product with verified serial number
- ✓Exit program for result maintenance
- ✓24/7 DOZA specialist support
Mounjaro 12.5 mg — detailed description
Mounjaro 12.5 mg — enhanced tirzepatide dose for the final stage of body contouring program. Prescribed for weeks 17-20 for clients who need a final boost to reach their target weight.
This is the second-highest potency dose of Mounjaro (maximum is 15 mg). At 12.5 mg, the dual GLP-1 + GIP mechanism operates at maximum intensity.
According to the SURMOUNT-1 study, participants on 12.5-15 mg doses achieved -20 to -22.5% weight loss from baseline. DOZA clients on 12.5 mg typically achieve -18 to -22 kg from program start.
After reaching target weight, DOZA specialists will create an exit program to maintain your results.
How Mounjaro 12.5 mg works — tirzepatide mechanism of action
At the enhanced 12.5 mg dose, tirzepatide provides near-maximum action:
• Complete appetite control: most clients need only 2 small meals per day
• Intensive fat burning with maximum muscle mass preservation
• Metabolism normalization: insulin, triglyceride, and cholesterol levels improve
• Stable weight loss even after 4+ months on program
Clinical research
Mounjaro (tirzepatide 12.5 mg) — FDA approved 2022. Dual GLP-1 + GIP agonist. The /research page contains the full evidence base: SURMOUNT-1 / SURPASS-2 / FDA prescribing information.
- SURMOUNT-1: Tirzepatide once weekly for the treatment of obesity (NEJM 2022)PubMed · 2022
- SURPASS-2: Tirzepatide vs semaglutide in type 2 diabetes (NEJM 2021)PubMed · 2021
- FDA prescribing information — Mounjaro (tirzepatide)FDA prescribing information · 2022
Titration protocol to 12.5 mg (tirzepatide)
Starting dose — GI adaptation
First therapeutic dose
Intermediate step
Intermediate step
Increase when 10 mg effect is insufficient
Injection once weekly, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 12.5 mg: 20–22% over 72 weeks (based on clinical studies).
Who is Mounjaro 12.5 mg for
- Patients with BMI ≥35 for whom 10 mg is not effective enough
- Intermediate dose before the maximum (15 mg) — reduces side effects
- Patients with pronounced insulin resistance
Mounjaro 12.5 mg — compared to other doses
- 12.5 mg is the intermediate step between 10 and 15 mg
- Better tolerability than a 10→15 mg jump
- Average weight loss: ~20–22% over 72 weeks
Frequently asked questions about Mounjaro 12.5 mg
The 12.5 mg dose is prescribed for clients who have completed the full gradual escalation course (2.5 → 5 → 7.5 → 10 → 12.5) and need additional effect to reach their target weight. Transition only by specialist recommendation.
Anastasia Shapoval
Metabolic Programs and Weight Control Specialist
Weight loss program — step-by-step dose escalation
DOZA client reviews for Mounjaro 12.5 mg
Mounjaro 12.5 mg — felt results in 3 weeks. Lost 4 kg in the first month. Thermobox delivery, excellent quality. DOZA — support throughout the entire course.
Ordering Mounjaro 12.5 mg for the second time. Original Eli Lilly quality, fair price. DOZA — highly recommend.
All Mounjaro client results →
Before/after photos · numbers · timelines · reviews
Other Mounjaro dosages
Mounjaro 12.5 mg — buy in Ukraine from DOZA
Mounjaro 12.5 mg (Mounjaro 12,5 mg, tirzepatide) — original KwikPen by Eli Lilly for weight loss programs. Price 27 000 ₴ (≈ 6 750 ₴ per injection). Buy Mounjaro 12.5 mg in Ukraine through the DOZA online service with delivery within 1–2 days in a thermobox (cold chain 2–8°C).
Why does DOZA only work with the UK version? We stopped working with DE and ES versions after cases when clients didn't achieve expected results — likely due to storage condition violations during transport. The UK supply chain of Eli Lilly has the strictest quality control among European markets. Each KwikPen has a serial number verifiable on the manufacturer's official website.
Mounjaro 12.5 mg is suitable for weeks 17-20 of the tirzepatide protocol. Tirzepatide works through a dual GLP-1 + GIP mechanism — reducing appetite and improving glucose metabolism. The SURMOUNT-1 clinical trial showed up to 20% weight loss over 72 weeks.
DOZA offers exclusively the Mounjaro Made in U.K. version. Mounjaro 12.5 mg delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv) by Nova Poshta or courier in a thermobox. Free specialist consultation and support throughout the entire course included.
⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting a program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.